The US Food and Drug Administration (FDA) has rejected a proposal to use MDMA, commonly known as ecstasy or molly, for treating post-traumatic stress disorder (PTSD). The FDA was evaluating the use of this psychedelic drug, developed by Lykos Therapeutics, in combination with talk therapy. Lykos Therapeutics reported that the…
Copyright © 2023 Menhealthdomain.com [ [email protected] ]